Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinoma

Neoplasia

Volumn 13, Issue 11, 2011, Pages 1093-1100

  Soucek, Laura ^a,b   Buggy, Joseph J ^c   Kortlever, Roderik ^a   Adimoolam, Shanthi ^c   Monclús, Helena Allende ^b   Allende, Maria Teresa Salcedo ^b   Swigart, Lamorna Brown ^a   Evan, Gerard I ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^c PHARMACYCLICS INC   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; PCI 32765; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME INHIBITION; INSULINOMA; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR REGRESSION; TUMOR VASCULARIZATION;

EID: 81355164530     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.11980     Document Type: Article

References (17)

1. Porta C, Larghi P, Rimoldi M, Totaro MG, Allavena P, Mantovani A, and Sica A (2009). Cellular and molecular pathways linking inflammation and cancer. Immunobiology 214, 761-777.
2. Grivennikov SI, Greten FR, and Karin M (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
3. de Visser KE and Coussens LM (2006). The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13, 118-137.
4. Pelengaris S, Khan M, and Evan GI (2002). Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109, 321-334.
5. Zhou YP, Pena JC, Roe MW, Mittal A, Levisetti M, Baldwin AC, Pugh W, Ostrega D, Ahmed N, Bindokas VP, et al. (2000). Overexpression of Bcl-x(L) in β-cells prevents cell death but impairs mitochondrial signal for insulin secretion. Am J Physiol Endocrinol Metab 278, E340-E351.
6. Shchors K, Shchors E, Rostker F, Lawlor ER, Brown-Swigart L, and Evan GI (2006). The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β. Genes Dev 20, 2527-2538.
7. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, and Evan GI (2007). Mast cells are required for angiogenesis and macroscopic expansion of Mycinduced pancreatic islet tumors. Nat Med 13, 1211-1218.
8. Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, Li S, Pan Z, Thamm DH, Miller RA, et al. (2010). The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci USA 107, 13075-13080.
9. Pan Z, Scheerens H, Li SJ, Schultz BE, Sprengler PA, Burril LC, Mendonca RV, Sweeney MD, Scott KC, Grothaus PG, et al. (2007). Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase. ChemMedChem 2, 58-61.
10. Gilfillan AM and Tkaczyk C (2006). Integrated signalling pathways for mastcell activation. Nat Rev Immunol 6, 218-230.
11. Setoguchi R, Kinashi T, Sagara H, Hirosawa K, and Takatsu K (1998). Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice. Immunol Lett 64, 109-118.
12. Sainte-Laudy J, Boumediene A, Touraine F, Orsel I, Brianchon C, Bonnaud F, and Cogne M (2007). Use of both CD63 up regulation and IgE down regulation for the flow cytometric analysis of allergen induced basophil activation. Definition of an activation index. Inflamm Res 56, 291-296.
13. Chen J, Trounstine M, Alt FW, Young F, Kurahara C, Loring JF, and Huszar D (1993). Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int Immunol 5, 647-656.
14. Strouch MJ, Cheon EC, Salabat MR, Krantz SB, Gounaris E, Melstrom LG, Dangi-Garimella S, Wang E, Munshi HG, Khazaie K, et al. (2006). Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res 16, 2257-2265.
15. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, Khan WN, Maeda-Yamamoto M, Miura T, Han W, Hartman SE, et al. (1998). Involvement of Bruton's tyrosine kinase in Fce{open}RI-dependent mast cell degranulation and cytokine production. J Exp Med 187, 1235-1247.
16. Iwaki S, Tkaczyk C, Satterthwaite AB, Halcomb K, Beaven MA, Metcalfe DD, and Gilfillan AM (2005). Btk plays a crucial role in the amplification of Fc e{open}RImediat d mast cell activation by kit. J Biol Chem 280, 40261-40270.
17. Lawlor ER, Soucek L, Brown-Swigart L, Shchors K, Bialucha CU, and Evan GI (2006). Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 66, 4591-4601.